In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon "Claim your beauty" 1998 ad campaign includes sampling effort.

This article was originally published in The Rose Sheet

Executive Summary

AVON 1998 "CLAIM YOUR BEAUTY" AD CAMPAIGN TAKES REALISTIC APPROACH to beauty marketing with ads designed to demonstrate that "individual beauty knows no boundaries," Avon said. The company's newest ad effort was developed after research revealed a "significant backlash" among women against "hype, over-promise and [a] barrage of unrealistic imagery" in beauty advertising, Avon stated. Claiming that today's beauty advertisements all look alike, Avon said its new campaign has been established to communicate that its mission, vision and way of doing business set the company apart from its competition. Print ads are breaking in February issues of women's fashion, beauty and lifestyle books, including Elle, Allure and InStyle. Television spots began airing in January.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005064

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel